Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipopolysaccharide (LPS) core antigen is a conserved oligosaccharide region within the LPS molecule found on the outer membrane of all Gram-negative bacteria. The LPS consists of three regions: the lipid A anchor (the main endotoxin moiety), the core oligosaccharide (the "core antigen," attached to lipid A), and the distal O-antigen polysaccharide (highly variable and species-specific). The core region typically comprises a short array of unusual sugars (such as Kdo and heptoses) and is less variable than the O-antigen, making it an important cross-reactive antigenic target for immunodiagnostics and potential broad-spectrum Gram-negative vaccines. Functionally, the LPS core antigen is essential for maintaining membrane integrity, repelling harmful substances, and resisting host immune defenses. It also serves as a key antigenic marker for laboratory classification and serotyping of bacterial strains and species. When released during infection or bacterial lysis, LPS fragments with the core antigen can trigger severe innate immune responses, leading to fever, inflammation, or septic shock.
Outer membrane disruption: Drugs like polymyxins bind to the LPS core and lipid A, destabilizing the outer membrane and killing bacteria. Endotoxin neutralization: Experimental therapeutics (antibodies, peptides) may neutralize LPS or its core region to block inflammation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide core antigen of Gram-negative bacteria (LPS core antigen).